Evidence-Based Nutrition Guidelines in Pregnancy: Weight Gain Targets, Macronutrient Balance, and Fetal Development

During the first trimester, maternal metabolic demands require only a negligible caloric increment (approximately 85 kcal per day). Energy requirements increase substantially in the second trimester by roughly 285–360 kcal/day, and in the third trimester by approximately 450–475 kcal/day. Macronutrient distribution should prioritize high-biological-value protein (1.1–1.2 g per kg of pre-pregnancy body weight from pastured poultry, eggs, low-mercury fish, and legumes), low-glycemic complex carbohydrates to mitigate gestational diabetes risk, and long-chain omega-3 fatty acids (DHA/EPA) essential for fetal neurodevelopment and retinal maturation.

Gestational weight gain (GWG) must be individualized according to pre-pregnancy Body Mass Index (BMI) in accordance with Institute of Medicine (IOM) clinical guidelines. Women categorized as underweight (BMI < 18.5) are advised a total gain of 12.5–18 kg; normal-weight individuals (BMI 18.5–24.9) should gain 11.5–16 kg; overweight women (BMI 25.0–29.9) are restricted to 7–11.5 kg; and women presenting with obesity (BMI ≥ 30) should aim for 5–9 kg. First-trimester gain typically totals 0.5–2 kg, followed by a steady weekly progression of 0.3–0.5 kg. Inadequate gain elevates small-for-gestational-age risks, whereas excessive gain predisposes to macrosomia, operative delivery, and preeclampsia.

Obstetric and gynecological guidelines emphasize targeted supplementation of core micronutrients throughout gestation: 1. Folic acid (400–800 µg/day, preferably incorporating bioactive 5-MTHF to prevent neural tube defects); 2. Iodine (150–200 µg/day to support maternal-fetal thyroid hormone synthesis and neurocognitive development); 3. Vitamin D3 (1500–2000 IU/day for neonatal bone mineralization and maternal immune regulation); 4. Docosahexaenoic acid (DHA) (minimum 200 mg/day, rising to 400–600 mg/day in populations with low marine fish intake). Iron supplementation is not universally indicated and should be administered strictly upon laboratory confirmation of depleted ferritin stores to avoid oxidative stress.